Abingdon, United Kingdom · Founded 2006 · Privately Held (backing)
Operator of a clinical-stage oncology company intended to develop cancer gene therapies. Akamis Bio is based in Abingdon, United Kingdom and was founded in 2006. Its last reported valuation was $145 million in Jan 2023. It has raised $185 million.
Last reported valuation
$145.3M
Oct 2026
Priced at
—
Total raised
$184.6M
Last round
—
Team — not yet on record
No current team members for Akamis Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Akamis Bio with a free account
·The complete investor list: 25 names
·Watch Akamis Bio: the Monday email on marks, rounds and moves
